Post Marketing Surveillance Phase in Clinical Research
Bookmark this for an in depth look at the Post Marketing Surveillance Phase IV in clinical research. This crucial phase monitors the long term safety and efficacy of newly approved drugs in real-world settings identifying rare adverse events and optimizing usage. Essential for understanding a drugs complete life cycle and patient safety